303 related articles for article (PubMed ID: 33770473)
1. Evidence for additive and synergistic action of mammalian enhancers during cell fate determination.
Choi J; Lysakovskaia K; Stik G; Demel C; Söding J; Tian TV; Graf T; Cramer P
Elife; 2021 Mar; 10():. PubMed ID: 33770473
[TBL] [Abstract][Full Text] [Related]
2. RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene.
Pnueli L; Rudnizky S; Yosefzon Y; Melamed P
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4369-74. PubMed ID: 25810254
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Enhancer Function and Transcription.
Field A; Adelman K
Annu Rev Biochem; 2020 Jun; 89():213-234. PubMed ID: 32197056
[TBL] [Abstract][Full Text] [Related]
4. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.
Lee JE; Wang C; Xu S; Cho YW; Wang L; Feng X; Baldridge A; Sartorelli V; Zhuang L; Peng W; Ge K
Elife; 2013 Dec; 2():e01503. PubMed ID: 24368734
[TBL] [Abstract][Full Text] [Related]
5. Enhancer RNA: What we know and what we can achieve.
Han Z; Li W
Cell Prolif; 2022 Apr; 55(4):e13202. PubMed ID: 35170113
[TBL] [Abstract][Full Text] [Related]
6. Widespread transcriptional pausing and elongation control at enhancers.
Henriques T; Scruggs BS; Inouye MO; Muse GW; Williams LH; Burkholder AB; Lavender CA; Fargo DC; Adelman K
Genes Dev; 2018 Jan; 32(1):26-41. PubMed ID: 29378787
[TBL] [Abstract][Full Text] [Related]
7. Histone H3K4me1 and H3K27ac play roles in nucleosome eviction and eRNA transcription, respectively, at enhancers.
Kang Y; Kim YW; Kang J; Kim A
FASEB J; 2021 Aug; 35(8):e21781. PubMed ID: 34309923
[TBL] [Abstract][Full Text] [Related]
8. Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate.
Arnold PR; Wells AD; Li XC
Front Cell Dev Biol; 2019; 7():377. PubMed ID: 31993419
[TBL] [Abstract][Full Text] [Related]
9. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
[TBL] [Abstract][Full Text] [Related]
10. The emerging roles of eRNAs in transcriptional regulatory networks.
Mousavi K; Zare H; Koulnis M; Sartorelli V
RNA Biol; 2014; 11(2):106-10. PubMed ID: 24525859
[TBL] [Abstract][Full Text] [Related]
11. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.
Wang C; Lee JE; Lai B; Macfarlan TS; Xu S; Zhuang L; Liu C; Peng W; Ge K
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11871-11876. PubMed ID: 27698142
[TBL] [Abstract][Full Text] [Related]
12. Cytosine modifications modulate the chromatin architecture of transcriptional enhancers.
Mahé EA; Madigou T; Sérandour AA; Bizot M; Avner S; Chalmel F; Palierne G; Métivier R; Salbert G
Genome Res; 2017 Jun; 27(6):947-958. PubMed ID: 28396520
[TBL] [Abstract][Full Text] [Related]
13. Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.
Dorighi KM; Swigut T; Henriques T; Bhanu NV; Scruggs BS; Nady N; Still CD; Garcia BA; Adelman K; Wysocka J
Mol Cell; 2017 May; 66(4):568-576.e4. PubMed ID: 28483418
[TBL] [Abstract][Full Text] [Related]
14. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.
Kaikkonen MU; Spann NJ; Heinz S; Romanoski CE; Allison KA; Stender JD; Chun HB; Tough DF; Prinjha RK; Benner C; Glass CK
Mol Cell; 2013 Aug; 51(3):310-25. PubMed ID: 23932714
[TBL] [Abstract][Full Text] [Related]
15. The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription.
Mikhaylichenko O; Bondarenko V; Harnett D; Schor IE; Males M; Viales RR; Furlong EEM
Genes Dev; 2018 Jan; 32(1):42-57. PubMed ID: 29378788
[TBL] [Abstract][Full Text] [Related]
16. Intragenic Enhancers Attenuate Host Gene Expression.
Cinghu S; Yang P; Kosak JP; Conway AE; Kumar D; Oldfield AJ; Adelman K; Jothi R
Mol Cell; 2017 Oct; 68(1):104-117.e6. PubMed ID: 28985501
[TBL] [Abstract][Full Text] [Related]
17. Enhancer identification in mouse embryonic stem cells using integrative modeling of chromatin and genomic features.
Chen CY; Morris Q; Mitchell JA
BMC Genomics; 2012 Apr; 13():152. PubMed ID: 22537144
[TBL] [Abstract][Full Text] [Related]
18. Predicting enhancer transcription and activity from chromatin modifications.
Zhu Y; Sun L; Chen Z; Whitaker JW; Wang T; Wang W
Nucleic Acids Res; 2013 Dec; 41(22):10032-43. PubMed ID: 24038352
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional transcription initiation marks accessible chromatin and is not specific to enhancers.
Young RS; Kumar Y; Bickmore WA; Taylor MS
Genome Biol; 2017 Dec; 18(1):242. PubMed ID: 29284524
[TBL] [Abstract][Full Text] [Related]
20. Enhancers: emerging roles in cell fate specification.
Ong CT; Corces VG
EMBO Rep; 2012 Apr; 13(5):423-30. PubMed ID: 22491032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
